Literature DB >> 8600950

MR imaging of skeletal muscle hemangiomas. A report of 16 cases.

G Jenner1, V Söderlund, H F Bauer, O Brosijö.   

Abstract

PURPOSE: Our purpose was to evaluate how MR imaging depicts the vascular fibrofatty structure of hemangiomas.
MATERIAL AND METHODS: MR images of 16 histologically proven skeletal muscle hemangiomas were reviewed retrospectively in a nonblinded manner. One patient was examined at 0.5 T, 9 at 1.0 T, and 6 at 1.5 T, and the imaging protocols varied.
RESULTS: All lesions were lobulated/tubular. Signal characteristics of fat were seen in 13 lesions as lace-like thin septa within or around the tumor. All 16 studies exhibited a hyperintense signal on T2-weighted spin-echo (SE) (n=15) or T1-weighted fast fat suppressed inversion recovery SE images (n=1). Postcontrast images showed marked signal enhancement in parts of the areas, both of high and low T2-weighted signal. Surgical staging based on MR images was correct in all lesions.
CONCLUSION: MR images display the characteristic vascular fibrofatty structure of hemangiomas and may allow correct diagnosis.

Entities:  

Mesh:

Year:  1996        PMID: 8600950     DOI: 10.1177/02841851960371P129

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  3 in total

1.  Biopsy is not necessary for the diagnosis of soft tissue hemangiomas.

Authors:  Eugenio Rimondi; Andreas F Mavrogenis; Costantino Errani; Teresa Calabrò; Alberto Bazzocchi; Giancarlo Facchini; Salvatore Donatiello; Paolo Spinnato; Daniel Vanel; Ugo Albisinni; Patrizia Pelotti
Journal:  Radiol Med       Date:  2018-02-23       Impact factor: 3.469

2.  Skeletal muscle metastases on magnetic resonance imaging: analysis of 31 cases.

Authors:  Qi Li; Lei Wang; Shinong Pan; Hong Shu; Ying Ma; Zaiming Lu; Xihu Fu; Bo Jiang; Qiyong Guo
Journal:  Contemp Oncol (Pozn)       Date:  2016-08-04

Review 3.  The development of musculoskeletal radiology for 100 years as presented in the pages of Acta Radiologica.

Authors:  Mats Geijer; Fatih Inci; Nektarios Solidakis; Pawel Szaro; Bariq Al-Amiry
Journal:  Acta Radiol       Date:  2021-10-19       Impact factor: 1.990

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.